Finance News – Regeneron Pharmaceuticals

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Shares Crypto Assets Stock Cryptocurrency Stock Market Ethereum Price Markets Xrp Investment Stablecoin Blockchain Etf Sec Eth Bse Ipo Trade Index Solana Earnings Revenue Inflation Coinbase Interest Rates China Token Wall Street Nasdaq Sensex Federal Reserve Gold Treasury Traders Nse Usd Economy Bse Sensex Trade War Profit Tesla Sp 500 Digital Assets Fertilisers Solar Farms Jump Crypto Liquid Assets Federal Framework Dota 2 Sgt Workforce Solutions Stock Ipo Ncc Group

Filter by:

Regeneron Pharmaceuticals × Past year ×

CNBC Business • May 27, 2025

23andMe to delist from Nasdaq, deregister with SEC

The planned acquisition of most 23andMe assets by Regeneron Pharmaceuticals for $256 million will result in the company's withdrawal from public stock trading and regulatory report...

Read Full Article →

The Guardian – Business • May 19, 2025

Bankrupt DNA testing firm 23andMe to be purchased for $256m

Regeneron Pharmaceuticals’ acquisition of a consumer genetic testing company for $256 million during bankruptcy highlights a significant investment in genetic data assets, promptin...

Read Full Article →

CBC Business • May 19, 2025

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Regeneron’s acquisition of the financially troubled DNA testing firm could impact the handling of extensive genetic data, while addressing concerns about privacy and potential misu...

Read Full Article →